Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine

NCT05667246 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT05667246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05667246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine
Lead sponsor
Weill Medical College of Cornell University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 25, 2024
Completion date
December 31, 2026
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

terbinafine adverse reaction